Please provide your email address to receive an email when new articles are posted on . Biologic disease-modifying antirheumatic drugs used to treat juvenile rheumatic diseases are excluded entirely ...

If you are over the age of 65 and have rheumatoid arthritis (RA), your physician may not be treating you as aggressively as recommended by American College of Rheumatology (ACR). Updated in 2021, the ...

Paternal exposure to methotrexate before conception is not linked to increased risks for adverse birth outcomes, but ...

Please provide your email address to receive an email when new articles are posted on . The American College of Rheumatology has released its updated treatment guidelines for rheumatoid arthritis, ...

There are several effective treatments for RA, including DMARDs and biologics. Both types of medications control rheumatoid arthritis by lowering the inflammation that fuels it, but there are ...

The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) than in patients who ...

Use of disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA) was markedly lower among all major ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this 12-part journey ...

Researchers evaluated the risk for total hip and knee arthroplasty with regard to the use of NSAIDs, DMARDs, and TNF inhibitors in patients with psoriatic arthritis and ankylosing spondylitis.

After the first 6 months of disease-modifying antirheumatic drugs (DMARDs) use in patients with rheumatoid arthritis (RA), most very abnormal results newly seen in long-term routine laboratory ...